3,4-dihydroxyphenylacetic acid has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, IK; Tokuyama, S; Yamamoto, T | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Butorphanol; Cerebral Cortex; Corpus Striatum; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Mesencephalon; Morphine; Naloxone; Opioid-Related Disorders; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley | 2000 |